FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly paediatrics and endocrinology, and concerns treating decompensated diabetes mellitus. For this purpose, a complex therapy involving the introduction of insulin and lipotropic preparation is added by the introduction of the probiotic Bifiform Baby 0.5 g 1 time a day for 10 days.
EFFECT: method provides lipid metabolism correction that is manifested in normalising triglycerides, total cholesterol and beta-lipoproteins, as well as reduces a risk of formation and progression of fatty hepatosis in the given group of patients.
2 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ADJUSTING METABOLISM DISORDERS IN DIABETES MELLITUS PATIENTS | 1996 |
|
RU2157692C2 |
| METHOD OF CORRECTING INSULIN DOSAGE IN TREATING DIABETES MELLITUS | 1991 |
|
RU2009511C1 |
| METHOD OF TREATMENT OR EARLY LIPID METABOLISM DISTURBANCE IN PATIENT WITH DIABETES OF THE 1-TYPE | 1992 |
|
RU2072860C1 |
| METHOD OF TREATING PATIENTS WITH INSULIN-RESISTANT FORM OF DIABETES MELLITUS | 0 |
|
SU812288A1 |
| METHOD OF TREATMENT OF PATIENTS WITH DIABETIC RETINOPATHY | 1996 |
|
RU2140236C1 |
| METHOD FOR NONMEDICAMENTOUS CORRECTION OF IMMUNE DISORDERS IN PATIENTS AFFECTED WITH NEWLY DETECTED INSULIN-DEPENDENT DIABETES MELLITUS | 1994 |
|
RU2089164C1 |
| METHOD OF LIPID METABOLISM MODIFICATION | 1996 |
|
RU2071379C1 |
| METHOD OF TREATING NON-ALCOHOLIC LIVER DISEASE ACCOMPANYING TYPE 2 DIABETES MELLITUS | 2013 |
|
RU2538221C1 |
| PHARMACEUTICAL COMPOSITION BASED ON HEPATOPROTECTOR AND PREBIOTIC AND METHOD FOR PRODUCING AND APPLYING THE COMPOSITION | 2006 |
|
RU2318538C1 |
| HEPATOPROTECTOR FOR TREATING NON-ALCOHOLIC LIVER DISEASE IN TYPE 2 DIABETES MELLITUS | 2013 |
|
RU2537227C1 |
